Edition:
United States

Novocure Ltd (NVCR.O)

NVCR.O on Nasdaq

68.26USD
17 Jul 2019
Change (% chg)

$-0.47 (-0.68%)
Prev Close
$68.73
Open
$68.97
Day's High
$69.20
Day's Low
$67.94
Volume
642,049
Avg. Vol
579,119
52-wk High
$69.75
52-wk Low
$26.02

About

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Its TTFields delivery system is used for the treatment of glioblastoma (GBM)... (more)

Overall

Beta: 2.43
Market Cap(Mil.): $6,582.03
Shares Outstanding(Mil.): 95.77
Dividend: --
Yield (%): --

Financials

  NVCR.O Industry Sector
P/E (TTM): -- 32.70 34.16
EPS (TTM): -0.59 -- --
ROI: -19.71 14.09 12.64
ROE: -47.30 65.48 17.19

Earnings vs. Estimates